Compare Novo Nordisk A/S (NVO) vs Qurate Retail Inc Series A (QVCAQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Qurate Retail Inc Series A — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Qurate Retail Inc Series A trades at $0.05 (market cap $698.27K). The key difference: Novo Nordisk A/S is far larger — about 315823.4× Qurate Retail Inc Series A's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Qurate Retail Inc Series A pays none. Which is the better fit depends on your goals.
| NVO | QVCAQ | |
|---|---|---|
Market Cap | $220.53B | $698.27K |
Sector | Health | Consumer Cyclical |
52-Week High | $71.70 | $15.03 |
52-Week Low | $35.29 | $0.05 |
Enterprise Value | $239.49B | $4.73B |
Dividend Yield | 3.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Qurate Retail Inc Series A
Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, primarily using their televised shopping programs and via the Internet through their websites and mobile applications
Read more on QVCAQ →
